Cargando…

Metabolomics and random forests in patients with complex congenital heart disease

INTRODUCTION: It is increasingly common to simultaneously determine a large number of metabolites in order to assess the metabolic state of, or clarify biochemical pathways in, an organism (“metabolomics”). This approach is increasingly used in the investigation of the development of heart failure....

Descripción completa

Detalles Bibliográficos
Autores principales: Michel, Miriam, Laser, Kai Thorsten, Dubowy, Karl-Otto, Scholl-Bürgi, Sabine, Michel, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581308/
https://www.ncbi.nlm.nih.gov/pubmed/36277761
http://dx.doi.org/10.3389/fcvm.2022.994068
_version_ 1784812594163351552
author Michel, Miriam
Laser, Kai Thorsten
Dubowy, Karl-Otto
Scholl-Bürgi, Sabine
Michel, Erik
author_facet Michel, Miriam
Laser, Kai Thorsten
Dubowy, Karl-Otto
Scholl-Bürgi, Sabine
Michel, Erik
author_sort Michel, Miriam
collection PubMed
description INTRODUCTION: It is increasingly common to simultaneously determine a large number of metabolites in order to assess the metabolic state of, or clarify biochemical pathways in, an organism (“metabolomics”). This approach is increasingly used in the investigation of the development of heart failure. Recently, the first reports with respect to a metabolomic approach for the assessment of patients with complex congenital heart disease have been published. Classical statistical analysis of such data is challenging. OBJECTIVE: This study aims to present an alternative to classical statistics with respect to identifying relevant metabolites in a classification task and numerically estimating their relative impact. METHODS: Data from two metabolomic studies on 20 patients with complex congenital heart disease and Fontan circulation and 20 controls were reanalysed using random forest (RF) methodology. Results were compared to those of classical statistics. RESULTS: RF analysis required no elaborate data pre-processing. The ranking of the variables with respect to classification impact (subject diseased, or not) was remarkably similar irrespective of the evaluation method used, leading to identical clinical interpretation. CONCLUSION: In metabolomic classification in adult patients with complex congenital heart disease, RF analysis as a one-step method delivers the most adequate results with minimum effort. RF may serve as an adjunct to traditional statistics also in this small but crucial-to-monitor patient group.
format Online
Article
Text
id pubmed-9581308
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95813082022-10-20 Metabolomics and random forests in patients with complex congenital heart disease Michel, Miriam Laser, Kai Thorsten Dubowy, Karl-Otto Scholl-Bürgi, Sabine Michel, Erik Front Cardiovasc Med Cardiovascular Medicine INTRODUCTION: It is increasingly common to simultaneously determine a large number of metabolites in order to assess the metabolic state of, or clarify biochemical pathways in, an organism (“metabolomics”). This approach is increasingly used in the investigation of the development of heart failure. Recently, the first reports with respect to a metabolomic approach for the assessment of patients with complex congenital heart disease have been published. Classical statistical analysis of such data is challenging. OBJECTIVE: This study aims to present an alternative to classical statistics with respect to identifying relevant metabolites in a classification task and numerically estimating their relative impact. METHODS: Data from two metabolomic studies on 20 patients with complex congenital heart disease and Fontan circulation and 20 controls were reanalysed using random forest (RF) methodology. Results were compared to those of classical statistics. RESULTS: RF analysis required no elaborate data pre-processing. The ranking of the variables with respect to classification impact (subject diseased, or not) was remarkably similar irrespective of the evaluation method used, leading to identical clinical interpretation. CONCLUSION: In metabolomic classification in adult patients with complex congenital heart disease, RF analysis as a one-step method delivers the most adequate results with minimum effort. RF may serve as an adjunct to traditional statistics also in this small but crucial-to-monitor patient group. Frontiers Media S.A. 2022-10-05 /pmc/articles/PMC9581308/ /pubmed/36277761 http://dx.doi.org/10.3389/fcvm.2022.994068 Text en Copyright © 2022 Michel, Laser, Dubowy, Scholl-Bürgi and Michel. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Michel, Miriam
Laser, Kai Thorsten
Dubowy, Karl-Otto
Scholl-Bürgi, Sabine
Michel, Erik
Metabolomics and random forests in patients with complex congenital heart disease
title Metabolomics and random forests in patients with complex congenital heart disease
title_full Metabolomics and random forests in patients with complex congenital heart disease
title_fullStr Metabolomics and random forests in patients with complex congenital heart disease
title_full_unstemmed Metabolomics and random forests in patients with complex congenital heart disease
title_short Metabolomics and random forests in patients with complex congenital heart disease
title_sort metabolomics and random forests in patients with complex congenital heart disease
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581308/
https://www.ncbi.nlm.nih.gov/pubmed/36277761
http://dx.doi.org/10.3389/fcvm.2022.994068
work_keys_str_mv AT michelmiriam metabolomicsandrandomforestsinpatientswithcomplexcongenitalheartdisease
AT laserkaithorsten metabolomicsandrandomforestsinpatientswithcomplexcongenitalheartdisease
AT dubowykarlotto metabolomicsandrandomforestsinpatientswithcomplexcongenitalheartdisease
AT schollburgisabine metabolomicsandrandomforestsinpatientswithcomplexcongenitalheartdisease
AT michelerik metabolomicsandrandomforestsinpatientswithcomplexcongenitalheartdisease